One of the most popular plastic surgeries in recent years is breast augmentation or breast implant surgery. Women have relied on breast implants as a way to enhance their breasts, improve their confidence, or restore their post-baby body.

Breast implant surgeries have become increasingly popular all over the world, with more than 400,000 procedures done every year in the United States alone.

However, recent studies suggest that there might be an alarming link between breast implant surgery and breast cancer.

The United States Food and Drug Administration (FDA) has taken notice and has issued a warning to plastic surgeons and recipients of breast implants.

What is Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)?

Breast Implant-Associated Anaplastic Large Cell Lymphoma or BIA-ALCL is an uncommon type of cancer that forms in the scar tissue and fluid surrounding breast implants.

It is not a form of breast cancer, but it is classified as a lymphoma, which is a type of cancer that affects the immune system.

The FDA first alerted the public of this potential link between breast implants and BIA-ALCL in 2011. Since then, more and more cases of the disease have been reported all over the world.

BIA-ALCL is a relatively rare disease, but it is still a concern because it has been associated with breast implants. Some symptoms of BIA-ALCL could include swelling, pain, or a lump in the breast.

If you have any of these symptoms, it is essential to see your doctor immediately.

Breast Implant Recall and FDA Warnings

There have been various breast implant recalls due to associated risks, including BIA-ALCL. In 2019, the FDA issued a recall of Allergan textured breast implants and tissue expanders due to potential health hazards, including BIA-ALCL.

The FDA has also issued several warnings concerning the potential connection between breast implant surgery and cancer.

The organization suggests that women with silicone or saline breast implants continue to monitor their breasts and have regular checkups with their doctors.

Risks Associated with Breast Implant Surgery

While breast implant surgery is typically safe, it is not without risks. Some of the most common complications associated with breast implant surgery include asymmetry, breast pain, and capsular contracture.

Capsular contracture occurs when the body forms a capsule of scar tissue around the implant, which can lead to discomfort, hardening, and sometimes even implant rupture.

Other risks include changes in nipple sensation, rupture or leak of the implant, and infection. The risk of developing these complications increases with age, BMI, and smoking habits.

Legal Implications

With the increasing reports of BIA-ALCL and other complications associated with breast implant surgery, many women who have undergone breast implant surgery are starting to question the safety of the procedure.

Several lawsuits have been filed against breast implant manufacturers and plastic surgeons accused of not providing their patients with adequate warnings of the potential health risks of the surgery.

Some of the plaintiffs have alleged that the manufacturers have deliberately concealed the side effects of breast implants for years.

Allergan, for example, is currently facing a class-action lawsuit, where several women accuse the company of failing to warn them of the risks of developing BIA-ALCL.

Conclusion

Breast implant surgery is still a popular cosmetic procedure that can enhance a woman’s appearance and self-confidence. However, it is essential to consider the risks associated with the procedure before deciding to undergo it.

Women with breast implants must remain vigilant about changes in their breasts and ensure that they receive regular checkups with their doctors.

As medical research continues, we might learn more about the link between breast implant surgery and cancer.

For now, women should carefully weigh the potential risks and benefits of getting breast implants and discuss their concerns with their plastic surgeons.